Scaffold Hopping

Identifies new scaffolds by abstracting the essential steric and electronic features of a bioactive molecule into a 3D pharmacophore model, then screening virtual libraries for compounds that match the spatial arrangement of hydrogen bond donors, acceptors, and hydrophobic centroids without sharing the original scaffold.

• Input: A known active ligand or ligand-receptor complex
• Key software: MOE, Phase, LigandScout
• Advantage: Does not require the target protein structure
• Limitation: May produce hits that cannot physically fit the binding pocket

Uses volumetric comparison algorithms to find molecules with near-identical molecular shape and electrostatics but different atomic connectivity. Tools like ROCS (Rapid Overlay of Chemical Structures) align molecules based on Gaussian volume overlap rather than 2D substructure similarity.

• Metric: TanimotoCombo score combines shape and color (electrostatic) similarity
• Strength: Excellent at finding bioisosteric replacements
• Typical workflow: Conformational expansion of query → shape alignment → scoring and ranking

Deconstructs a known active molecule into its component fragments, identifies the minimal pharmacophoric elements responsible for binding, then computationally reconnects these fragments with novel linker chemistry or alternative core templates.

• Key concept: Retain critical binding motifs, replace the central scaffold
• Tools: BREED, RECAP, BROOD
• Output: Hybrid molecules combining proven binding elements with novel cores
• Risk: Synthetic accessibility of the proposed reconnections must be validated

Leverages variational autoencoders (VAEs) and generative adversarial networks trained on chemical space to sample novel molecules in the latent neighborhood of an active compound. By traversing the learned continuous representation, the model generates structures with similar predicted activity but divergent scaffolds.

• Architectures: Junction Tree VAE, MolGAN, GraphINVENT
• Advantage: Truly de novo scaffold generation beyond enumerated libraries
• Validation: Generated molecules must be scored for synthetic accessibility (SA score) and drug-likeness (QED)

Systematically replaces substructures with known bioisosteres—functional groups or ring systems that exhibit similar physicochemical properties and biological activity. Curated databases like BIOSTER and SwissBioisostere catalog thousands of validated replacements mined from medicinal chemistry literature and patent data.

• Classic example: Replacing a carboxylic acid with a tetrazole or acylsulfonamide
• Ring equivalents: Swapping phenyl for thiophene, pyridine, or saturated bicyclic systems
• Benefit: High success rate due to precedent-based design

Analyzes large structure-activity relationship (SAR) datasets to identify single-point chemical transformations that maintain or improve potency while altering the core. By mining internal compound archives for matched pairs differing only in the scaffold region, teams can data-mine successful scaffold hops.

• Data requirement: Large, internally consistent assay datasets
• Output: Statistical probability of activity retention for specific scaffold swaps
• Integration: Often combined with Free-Wilson analysis for quantitative contribution mapping

The strategic substitution of one chemical substructure with another that exhibits similar steric and electronic properties while producing comparable biological activity. This is the foundational design principle enabling scaffold hopping.

• Classical bioisosteres: Direct atom-for-atom replacements (e.g., -OH for -NH2)
• Non-classical bioisosteres: Functional group swaps that retain activity but differ in atom count, ring topology, or valence electrons
• Key objective: Maintain the pharmacophoric pattern while altering the core scaffold to escape patent claims or improve metabolic stability

A computational strategy that abstracts the essential 3D arrangement of chemical features required for target binding, then searches for novel scaffolds that present these features in the same spatial orientation.

• Defines features: Hydrogen bond donors/acceptors, hydrophobic centroids, aromatic rings, and ionizable groups
• Excludes the scaffold itself from the query, enabling true scaffold independence
• Often combined with shape-based screening to add steric constraints
• Tools: Phase, MOE Pharmacophore Discovery, LigandScout

A ligand-based virtual screening method that ranks compounds by the volume overlap of their low-energy conformations with a reference active molecule, independent of underlying chemical structure.

• Uses Gaussian functions to represent molecular shape as a continuous electron density-like field
• ROCS (Rapid Overlay of Chemical Structures) is the industry-standard implementation
• Complements pharmacophore methods by capturing steric constraints that feature-based queries miss
• Effective for identifying scaffolds with radically different chemotypes that occupy the same binding pocket volume

A scaffold discovery approach that begins with low molecular weight fragments (typically < 250 Da) identified through biophysical screening, then grows or links them into novel lead compounds.

• Fragment growing: Extending a bound fragment into adjacent binding pocket regions
• Fragment linking: Connecting two fragments that bind to proximal sites with an appropriate linker
• Fragment merging: Combining structural features from overlapping fragments into a single scaffold
• Produces highly ligand-efficient starting points with novel intellectual property positions

A systematic data-mining technique that identifies pairs of compounds differing only by a single structural transformation at a specific site, enabling the isolation of that change's impact on activity and properties.

• Reveals bioisosteric replacement rules from experimental data
• Quantifies the effect of scaffold changes on potency, solubility, and metabolic clearance
• Builds a knowledge base of validated scaffold transitions for future hopping campaigns
• Algorithmically identifies transformations that maintain activity while improving ADMET profiles

A computational comparison method that evaluates scaffold candidates based on the spatial distribution of their molecular electrostatic potential rather than their 2D structure or atom connectivity.

• Calculated from partial charges mapped onto a molecular surface or grid
• Identifies scaffolds with identical charge patterns despite completely different bonding frameworks
• Critical for targets where electrostatic complementarity dominates binding affinity
• Tools: Cresset FieldAlign, OpenEye EON
• Particularly effective when combined with shape similarity for a holistic field-based comparison